Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01290796 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Ajust™ in Stress Urinary Incontinence
A NA study, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 153
- Enrollment target
NCT01290796: Completed NA study, sponsored by C. R. Bard.
NCT01290796 is a NA study that has completed, run by C. R. Bard. The registered enrollment target is 153 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01290796, a NA study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 153 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the overall effectiveness of the Ajust Adjustable Single-Incision Sling in the surgical treatment of female stress urinary incontinence.
Primary Outcome
Percentage of patients who are free of stress urinary incontinence, as assessed by a negative (-) Cough Stress Test (CST) and no surgical retreatment, at the 12 month study visit.
Interventions
- DEVICE Ajust Adjustable Single-Incision Sling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2011-01 |
| Est. Completion | 2015-10 |
| Phase | NA |
What the finished NCT01290796 record still lists
NCT01290796 is an interventional study that assigns participants to a tested intervention. The registered 153 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 1 intervention - of which Ajust Adjustable Single-Incision Sling is the first listed.
NCT01290796 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01290796 about?
NCT01290796 is a clinical study titled "Clinical Evaluation of Ajust™ in Stress Urinary Incontinence". The purpose of this study is to assess the overall effectiveness of the Ajust Adjustable Single-Incision Sling in the surgical treatment of female stress urinary incontinence.
What is the current status of trial NCT01290796?
This trial is currently completed. It is a NA study. The enrollment target is 153 participants. The study started on 2011-01. Estimated completion is 2015-10.
What interventions are being tested in trial NCT01290796?
The interventions under investigation include: Ajust Adjustable Single-Incision Sling (DEVICE).
Who is sponsoring clinical trial NCT01290796?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01290796's enrollment target sits among peer trials
153 656th of 2000 higher than 1,343 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05283265 · 153 participants · NA
Neurophysiological Mechanisms of Language Comprehension
- NCT05554393 · 153 participants · Phase 2
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- NCT05584501 · 153 participants · NA
ETE Interventions in the Dental Setting
- NCT05714839 · 153 participants · Phase 1
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia